Zdrowie i gospodarka · 20/05/2021

FDA Clears NORMODYNE (Labetalol Hydrochloride) Injection for Continued Sale

The US Food and Drug Administration (FDA) has ruled that NORMODYNE (labetalol hydrochloride) injection, 5 mg/mL, was not withdrawn from the market due to safety or efficacy concerns, allowing the FDA to continue approving abbreviated new drug applications (ANDAs) for the product.